Skip to content
Every ranking computed from public data · Every price carries a verification status and date · How we rank Affiliate disclosure · Ownership
Free tool · runs in your browser · nothing is sent to a server

GLP-1 Eligibility Screener: Do You Meet the FDA Label Criteria for Tirzepatide or Semaglutide?

A screener that applies the FDA label criteria for Zepbound and Wegovy — BMI thresholds, weight-related conditions, and the contraindications that rule treatment out — before you spend time on a telehealth intake.

Enter your weight and height.

What the screener checks

It applies the label criteria: BMI of 30 or higher, or 27 or higher with at least one weight-related condition, and it flags the absolute contraindications (medullary thyroid carcinoma or MEN 2 history, pregnancy) and the conditions that need individual assessment (pancreatitis, type 1 diabetes). It runs in your browser; nothing is sent anywhere.

What it cannot check

A clinician will also ask about kidney function, gallbladder disease, gastroparesis, diabetic retinopathy, depression or suicidal ideation, alcohol use, current medications (especially insulin and sulfonylureas, which raise hypoglycemia risk), and planned surgery (GLP-1s delay gastric emptying and anesthesia teams need to know). Passing the screener means you meet the label's basic criteria, not that a GLP-1 is right for you.

If you meet the criteria

The next step is a telehealth intake or a visit with your own clinician. The best GLP-1 telehealth page describes what the intake and approval process looks like and how providers differ on payment timing.

Frequently asked questions

Can I get a GLP-1 with a BMI under 27?

The FDA labels for weight management do not cover BMI under 27. A clinician may prescribe off-label, and some telehealth providers do, but the trial evidence and the labeled benefit-risk balance are for BMI 27 and above.

What rules out a GLP-1 entirely?

A personal or family history of medullary thyroid carcinoma or MEN 2, a prior serious hypersensitivity reaction to the drug, pregnancy or breastfeeding, and (for combination) current use of another GLP-1 agonist. Pancreatitis history, severe gastroparesis, and diabetic retinopathy call for individual clinical judgment.

Editor's pick · best overall

Editor's pick: NexLife value score 91/100

How the pick is chosen: the highest value score in our database (cost, transparency, flexibility, care and verification) as of September 12, 2026; it changes automatically when the data does. The pick is computed, not sold: NexLife is a commercial partner of this site (named in the ownership disclosure), which is why this module and its links are labeled; the formula can and does place it below cheaper providers (currently 5 of 34 on tirzepatide 12-month cost, 5 of 16 on semaglutide). How the score works · Advertising disclosure.

What every plan includes

  • Same price at every dose. No hidden fees.
  • Free expedited shipping.
  • No membership fees.
  • Doctor-led plans, coaching and an active community.

Prices verified, checked September 12, 2026.

Included at no extra cost

  • Provider review and ongoing medical guidance$199Included
  • Personalized nutrition plan (GLP-1 focused)$99Included
  • 1:1 fitness call with a certified wellness coach$79Included

Stated values are NexLife's own figures, not market prices.

Plan pages

Regular protocol Standard injectable plans; the ones our rankings use
Microdose protocol Lower-dose plans; listed in our database, not ranked
Sublingual (ODT) protocol Orally disintegrating tablets; listed, not ranked

Read the full review and the cons →